- Patent Number:
11931,171
- Appl. No:
16/963123
- Application Filed:
January 15, 2019
- نبذة مختصرة :
The present disclosure is related to a method and apparatus for determining drug usage or a physiological characteristic of a patient. The present disclosure describes acquiring a video sequence, of an eye of a patient, the video sequence being a plurality of video frames, determining a frequency spectrum from a pupillary data of the video sequence, and determining, based on the frequency spectrum, the physiological characteristic or drug of use of the patient. In an embodiment, at least one frequency can be probed based on which physiological characteristic is being explored.
- Inventors:
CHILDREN'S NATIONAL MEDICAL CENTER (Washington, DC, US)
- Assignees:
CHILDREN'S NATIONAL MEDICAL CENTER (Washington, DC, US)
- Claim:
1. An apparatus for evaluation of a pupillary hippus of a patient, comprising: a display; and processing circuitry configured to transform experimental data of the pupillary hippus of the patient and reference data via frequency-based transformation, calculate a first parameter of one or more selected parameters based upon the transformed experimental data of the pupillary hippus of the patient, calculate, based upon the transformed reference data, a corresponding first parameter of the one or more selected parameters, generate a metric from the first parameter based upon the experimental data and the corresponding first parameter based upon the reference data, the generated metric being a normalization of the first parameter and the corresponding first parameter, determine whether the generated metric achieves a predetermined threshold, the predetermined threshold being related to a biologically-active target, and display, on the display and based upon the determination, the evaluation of the pupillary hippus of the patient, wherein the evaluation of the pupillary hippus of the patient is an identification of the biologically-active target, the biologically-active target being selected from a group including alcohol, opioids, cannabinols, alpha-2 agonists, benzodiazepines, ketaminemorphine, morphine-3-glucuronide, morphine-6-glucuronide, or a combination thereof.
- Claim:
2. The apparatus according to claim 1 , wherein the processing circuitry is further configured to determine whether the generated metric achieves the predetermined threshold based upon a correlation between the first parameter of the experimental data and the corresponding first parameter of the reference data.
- Claim:
3. The apparatus according to claim 1 , wherein the first parameter based upon the experimental data is an amplitude at a predetermined frequency.
- Claim:
4. The apparatus according to claim 1 , wherein the first parameter based upon the experimental data is band power.
- Claim:
5. The apparatus according to claim 1 , wherein the generated metric is a difference between a band power of the experimental data and a band power of the reference data.
- Claim:
6. The apparatus according to claim 1 , wherein the first parameter based upon the experimental data is a mathematical model of the experimental data.
- Claim:
7. The apparatus according to claim 6 , wherein the first parameter based upon the experimental data is a mathematical model of a frequency spectrum of the experimental data.
- Claim:
8. The apparatus according to claim 1 , wherein the generated metric is a similarity ratio of mathematical models of a frequency spectrum of the experimental data and of the reference data.
- Claim:
9. The apparatus according to claim 1 , wherein the processing circuitry is further configured to acquire a plurality of video sequences of an eye of the patient, generate pupillary data based upon primary data calculated from the plurality of video sequences, the primary data including time-based pupillary dimensions, and calculate, from the generated pupillary data, secondary data, wherein the secondary data include the frequency spectrum of the pupillary hippus.
- Claim:
10. The apparatus according to claim 9 , wherein the primary data are calculated based upon a mask image, the processing circuitry, in order to generate the mask image, being further configured to locate a center of a pupil of the eye, a boundary of the pupil of the eye, and an iris of the eye, and generate the mask image, the mask image corresponding to an expected location of the iris based upon the location of the center of the pupil of the eye, the boundary of the pupil of the eye, and the iris of the eye.
- Claim:
11. An apparatus for evaluation of a pupillary hippus of a patient, comprising: a display; and processing circuitry configured to calculate a first parameter of one or more selected parameters based upon experimental data of the pupillary hippus of the patient, calculate, based upon reference data of a pupillary hippus, a corresponding first parameter of the one or more selected parameters, generate a metric from the first parameter based upon the experimental data and the corresponding first parameter based upon the reference data, the generated metric being a normalization of the first parameter and the corresponding first parameter, determine whether the generated metric achieves a predetermined threshold, the predetermined threshold being related to a biologically-active target, and display, on the display and based upon the determination, the evaluation of the pupillary hippus of the patient, wherein the evaluation of the pupillary hippus of the patient is an identification of the biologically-active target, the biologically-active target being selected from a group including alcohol, opioids, cannabinols, alpha-2 agonists, benzodiazepines, ketaminemorphine, morphine-3-glucuronide, morphine-6-glucuronide, or a combination thereof.
- Claim:
12. The apparatus according to claim 11 , wherein the processing circuitry is further configured to determine whether the generated metric achieves the predetermined threshold based upon a correlation between the first parameter of the experimental data and the corresponding first parameter of the reference data.
- Claim:
13. The apparatus according to claim 11 , wherein the processing circuitry is further configured to transform the experimental data of the pupillary hippus of the patient and the reference data via frequency-based transformation, and the generated metric is a difference between a band power of the experimental data and a band power of the reference data.
- Claim:
14. The apparatus according to claim 11 , wherein the processing circuitry is further configured to transform the experimental data of the pupillary hippus of the patient and the reference data via frequency-based transformation, and the generated metric is a similarity ratio of mathematical models of a frequency spectrum of the experimental data and of the reference data.
- Claim:
15. The apparatus according to claim 11 , wherein the processing circuitry is further configured to acquire a plurality of video sequences of an eye of the patient, generate pupillary data based upon primary data calculated from the plurality of video sequences, the primary data including time-based pupillary dimensions, and calculate, from the generated pupillary data, secondary data, wherein the secondary data include the frequency spectrum of the pupillary hippus.
- Claim:
16. The apparatus according to claim 15 , wherein the primary data are calculated based upon a mask image, the processing circuitry, in order to generate the mask image, being further configured to locate a center of a pupil of the eye, a boundary of the pupil of the eye, and an iris of the eye, and generate the mask image, the mask image corresponding to an expected location of the iris based upon the location of the center of the pupil of the eye, the boundary of the pupil of the eye, and the iris of the eye.
- Claim:
17. The apparatus according to claim 11 , wherein the processing circuitry is further configured to transform the experimental data of the pupillary hippus of the patient via frequency-based transformation, and remove, from the transformed experimental data, data according to a predetermined frequency range.
- Claim:
18. The apparatus according to claim 11 , wherein the evaluation of the pupillary hippus of the patient can be an identification of a presence of a dysautonomia, the dysautonomia being one selected from a group including postural orthostatic tachycardia syndrome and diabetic neuropathy.
- Claim:
19. An apparatus for evaluation of a pupillary hippus of a patient, comprising: processing circuitry configured to calculate a first parameter of one or more selected parameters based upon experimental data of the pupillary hippus of the patient, calculate, based upon reference data of a pupillary hippus, a corresponding first parameter of the one or more selected parameters, generate a metric from the first parameter based upon the experimental data and the corresponding first parameter based upon the reference data, the generated metric being a normalization of the first parameter and the corresponding first parameter, determine whether the generated metric achieves a predetermined threshold, the predetermined threshold being related to a biologically-active target, and display, on a display and based upon the determination, the evaluation of the pupillary hippus of the patient, wherein the evaluation of the pupillary hippus of the patient is an identification of the biologically-active target, the biologically-active target being selected from a group including alcohol, opioids, cannabinols, alpha-2 agonists, benzodiazepines, ketaminemorphine, morphine-3-glucuronide, morphine-6-glucuronide, or a combination thereof.
- Patent References Cited:
9357966 June 2016 Cohen
20020024633 February 2002 Kim et al.
20090161923 June 2009 Kondo et al.
20110170064 July 2011 Taylor
20110251468 October 2011 Osorio
20140268047 September 2014 Hirsh
20160192837 July 2016 Neice
20160381453 December 2016 Ushakov
20170100061 April 2017 Finkel
104586386 May 2015
104586410 May 2015
106793942 May 2017
111918600 November 2020
2001-195594 July 2001
2006-326326 December 2006
2016-537152 December 2016
2017-529891 October 2017
WO 2013/059656 April 2013
WO-2013059656 April 2013
WO 2015/042413 March 2015
WO 2016/022414 February 2016
- Other References:
Office Action dated Dec. 6, 2022 in Japanese Patent Application No 2020-539732 (with English translation), 14 pages. cited by applicant
Office Action dated Mar. 7, 2021 in corresponding Israeli Patent Application No. 275862, 2 pages. cited by applicant
Office Action dated Nov. 12, 2021 in corresponding Indian Patent Application No. 202017030155 (with English Translation), 7 pages. cited by applicant
International Search Report and Written Opinion dated Mar. 27, 2019 in PCT/US2019/013671 filed on Jan. 15, 2019. cited by applicant
Rosenberg et al., “Pupillary Hippus: an Unrecognized Example of Biologic Chaos”, Journal of Biological Systems, 1999, vol. 7, No. 1, Retrieved from the Internet: , pp. 85-94. cited by applicant
Extended European Search Report dated Oct. 14, 2021 in corresponding European Patent Application No. 19740728.1, 9 pages. cited by applicant
Israeli Office Action dated Jul. 17, 2023 in Israeli Patent Application No. 275862 (with English translation) 13 pages. cited by applicant
Office Action dated Jan. 9, 2024, issued in counterpart KR Application No. 10-2020-7023416 filed Aug. 13, 2020, with English machine translation. (24 pages). cited by applicant
Examination Report dated Nov. 2, 2023, in Australian Patent Application No. 2019209323, citing document 24, therein, 5 pages. cited by applicant
Bokoch et al., “Fentanyl, an agonist at the mu opioid receptor, depresses pupillary unrest”—Autonomic Neuroscience: Basic and Clinical 189 (2015) 68-74 (abstract only). cited by applicant
Office Action dated Nov. 3, 2023 in Chinese Application No. 201980013097.0, along with an English translation. cited by applicant
- Primary Examiner:
Hasan, Mohammed A
- Attorney, Agent or Firm:
Oblon, McClelland, Maier & Neustadt, L.L.P.
- الرقم المعرف:
edspgr.11931171
Processing Request
No Comments.